A prospective, multicenter real-world study, dubbed ADHERE REAL (NCT07264426), will evaluate the effectiveness of ...
EpilepsyGTx and Viralgen have entered a collaboration to support manufacturing of EPY201, an investigational adeno-associated virus (AAV)-based gene therapy being developed for patients with focal ...
Dravet syndrome begins deceptively. Infants who appear completely normal in the first year of life develop their first ...
The FDA extended its review of relutrigine for SCN2A- and SCN8A-related epilepsies by three months, pushing the PDUFA date to ...
SHIELD randomizes ~150 adults (18–65 years) to placebo-controlled evaluation of valacyclovir/celecoxib with an added 25-day ...
NeurologyLive Brain Games is a weekly quiz series that goes live every Sunday morning, featuring questions on a variety of ...
The FDA has approved tavapadon (AbbVie), a once-daily oral selective dopamine D1/D5 receptor partial agonist, for adults with ...
Exploring the Link Between Football Players and ALS: Brian Lin, PhD In a recent Q&A interview, Brian Lin, PhD, research ...
The professor of neurology at the University of Cincinnati discussed how clinical awareness of social determinants and expanded telehealth have begun to move the needle for stroke care. [WATCH TIME: 7 ...
Beginning with FDA news, the administration Xenon Pharmaceuticals has submitted a new drug application (NDA) to the FDA for ...
A retrospective cohort study found DTI-ALPS, a glymphatic function marker, did not independently predict survival in ...
Neurology moves fast, and the assumptions that shape how we practice do not always keep up. Gray Areas is a NeurologyLive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results